Shawn Marie Soderberg, Chief Legal Officer and Corporate Secretary of Bloom Energy Corp (NYSE:BE), filed a Form 4 on September 18, 2026, disclosing the sale of 2,870 shares of common stock on September 16, 2026, to cover tax withholding obligations arising from the settlement …
Maciej Kurzymski, Chief Accounting Officer of Bloom Energy Corp (NYSE:BE), filed a Form 4 on September 18, 2026, disclosing the sale of 2,295 shares of common stock on September 16, 2026, to cover tax withholding obligations upon the settlement of restricted stock units.
Aman Joshi, Chief Commercial Officer of Bloom Energy Corp (NYSE:BE), filed a Form 4 on September 18, 2026, disclosing the sale of 3,601 shares of common stock on September 16, 2026, to cover tax withholding obligations upon the settlement of restricted stock units.
Nippon Life Insurance Co filed a Form 4 with the SEC on September 18, 2026, disclosing the purchase of 320,785 shares of Corebridge Financial, Inc. common stock on September 16, 2026, under a Rule 10b5-1 plan.
Tara M. Tereso, Group Executive of IDEX Corporation's Health and Science Technologies segment, filed a statement of changes in beneficial ownership on September 18, 2026, reporting a disposition of common stock on September 16, 2026.
Stephen Michael Kelsey, Senior Advisor to the Chief Executive Officer at Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, disclosing the sale of common stock on September 16, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Anthony Mancini, Chief Global Commercialization Officer of Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, disclosing the sale of common stock on September 16, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.
Alan B. Sandler, Chief Development Officer of Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, reporting two sales of common stock on September 16, 2026, executed under a pre-established Rule 10b5-1 trading plan.
Michael Linford, President of Affirm Holdings, Inc., filed a Form 4 on September 18, 2026, disclosing the acquisition of 67,006 restricted stock units in the company's Class A Common Stock on September 16, 2026.
Libor Michalek, President and Director of Affirm Holdings, Inc. (NASDAQ:AFRM), filed a Form 4 on September 18, 2026, disclosing the acquisition of 67,006 Restricted Stock Units on September 16, 2026.